Posted on: June 12, 2012 by Jonathan Marino
California-based antibody biopharma company Igenica has raised $33 million in a Series C round led by new investor Third Rock Ventures. Existing backers The Column Group, Orbimed Advisors and 5AM Ventures participated in the round; Igenica has raised about $55 million to date. PRESS RELEASE: BURLINGAME, Calif., June 12, 2012 /PRNewswire/ — Igenica, Inc., a [...]
Tags: The Column Group, Third Rock Ventures
Posted on: June 7, 2011 by Jonathan Marino
Cyterix Pharmaceutics has landed $9.2 million from The Column Group and SV Life Sciences for its Series A Round. As part of the transaction, Tim Kutzkey, Ph.D., Partner at The Column Group, and Lutz Giebel, Ph.D., Managing Partner at SV Life Sciences, have joined the Cyterix Board of Directors. The company was founded in 2010.
Tags: SV Life Sciences, The Column Group
Posted on: June 6, 2011 by cnolan
Constellation Pharmaceuticals has raised $15 million in an extension to its Series B round, the company announced Monday. Third Rock Ventures, The Column Group, Venrock Associates, SR One and Altitude Life Science Ventures – all existing shareholders – participated in the round. The latest infusion will help Constellation move its products toward clinical development. The company develops small molecule therapeutics for the treatment of cancer, inflammatory and immunologic disorders and other diseases.
Tags: Altitude Life Science Ventures, SR One, The Column Group, Third Rock Ventures, Venrock Associates
Posted on: May 21, 2009 by PEHub Administrator
Aragon Pharmaceuticals raised $8 million in Series A financing led by The Column Group and OrbiMed Advisors. Press release: Aragon Pharmaceuticals today announced it has raised $8 million in Series A financing led by The Column Group and OrbiMed Advisors. Funds from the Series A financing will be used to discover and develop new small [...]
Tags: Aragon Pharmaceuticals, OrbiMed Advisors, The Column Group